Atlas Trials

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

Clinical trial NCT03606577 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03606577
Sponsor
Nantes University Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2019-07-30
Primary completion
2022-02-08
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.